| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,873 |
3,751 |
$184K |
| 87428 |
|
650 |
639 |
$37K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
321 |
271 |
$31K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
306 |
256 |
$30K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
363 |
321 |
$29K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
272 |
241 |
$20K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
707 |
695 |
$7K |
| 87481 |
|
24 |
24 |
$5K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
37 |
37 |
$5K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
75 |
70 |
$5K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
68 |
67 |
$3K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
219 |
215 |
$3K |
| 81025 |
|
294 |
287 |
$1K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
32 |
31 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
44 |
44 |
$742.19 |
| 81002 |
|
365 |
351 |
$738.99 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
15 |
15 |
$620.70 |
| 87480 |
|
14 |
14 |
$560.62 |
| 87660 |
|
14 |
14 |
$493.35 |
| 87088 |
|
25 |
25 |
$491.01 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
44 |
37 |
$375.40 |
| 87070 |
|
14 |
12 |
$297.58 |
| 81001 |
|
38 |
38 |
$276.02 |